🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The current study assesses the tolerability and efficacy of monotherapy wit...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-09-12
Trial ID
NCT05465174
Treatments Being Tested
The main purpose of this study is to determine effect of orforglipron capsu...
Status
Completed
Location
Fortrea Clinical Research Unit Inc.
Start Date
2024-01-02
Trial ID
NCT06186622
Treatments Being Tested
This phase II trial tests the safety, side effects, best dose and activity ...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2024-03-28
Trial ID
NCT05828069
The proposed study will carefully test the hypothesis that a robust dose of...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2013-12-12
Trial ID
NCT01980706
This research study is studying a drug Tovorafenib/DAY101 (formerly TAK-580...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2018-02-27
Trial ID
NCT03429803
Treatments Being Tested
Rationale: Giving bortezomib and low doses of chemotherapy and total-body i...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00995059
This is a subprotocol of Master Protocol DAY101-102 and is a Phase 1b/2, mu...
Status
Terminated
Location
The Angeles Clinic
Start Date
2022-05-02
Trial ID
NCT07121829
Treatments Being Tested
This phase II trial studies how well giving an umbilical cord blood transpl...
Status
Completed
Location
University of Colorado Hospital
Start Date
2005-11-18
Trial ID
NCT00719888
This phase I/II trial tests the safety, side effects, and effectiveness of ...
Status
Recruiting
Location
NCI - Center for Cancer Research
Start Date
2026-05-29
Trial ID
NCT06965114
This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial...
Status
Active Not Recruiting
Location
Children's of Alabama
Start Date
2023-02-27
Trial ID
NCT05566795
Treatments Being Tested